Table 1.
Epidemiologic characteristics, clinical features, hospitalization, echocardiography findings, treatment modality, and outcome of 904 children with suspected SARS-CoV-2 infection
| Characteristic | Value |
|---|---|
| Age Median (range) | 168 (3-206) mo |
| Age Group Distribution — no. (%) | |
| <1 yr | 81 (9) |
| 1–5 yr | 416 (46) |
| 6–10 yr | 271 (30) |
| 11–15 yr | 136 (15) |
| Sex — no. (%) | |
| Male | 650 (72) |
| Female | 254 (28) |
| Diagnosis information — no. (%) | |
| Confirmed Cases | 138 (15%) |
| Confirmed family members | 904 (100%) |
| Fever — no. (%) | 671 (74) |
| Median duration of fever (range) — days | 3 (1–11) |
| Diarrhea — no. (%) | 70 (7. 7) |
| Sore throat— no. (%) | 91 (10.1) |
| Coriza symptoms— no. (%) | 345 (38.2) |
| Abdominal pain— no. (%) | 104 (11.5) |
| Vomiting— no. (%) | 70 (7.75 |
| Skin rash— no. (%) | 14 (1.5) |
| Bacterial Superinfection | |
| AOM | 20 (2.2) |
| ABRS | 40 (4.4) |
| Abnormalities on echocardiography Number. (%) | |
| Mitral regurgitation | 21 (44.4) |
| Mild Pericardial effusion | 35 (75.6) |
| Tricuspid regurgitation | 17 (37.8) |
| Coronary aneurysm | 9 (20) |
| Myocarditis | 6 (13.3) |
| Duration of hospitalization Median (range) day | 5.7 (2–13) |
| Treatment | |
| IVIG | 12 (21.8) |
| Glucocorticoid | 41 (74.5) |
| ICU Care— no. (%) | 7 (12.7) |
| Intubation— no. (%) | 2 (3.6) |
| Death | 2 (3.6) |
| Remission | 53 (96.4) |
AOM: Acute Otitis Media, ABRS: Acute Bacterial Rhinosinusitis